Free Newsletter
RFID still garners big forecast
Vendors are offering pilot kits to help drugmakers get a handle on the little understood business case for RFID technology. Delays in retailer and regulatory supply chain mandates have hampered adoption, says GBI Research, which forecasts annual industry growth of 34 percent through 2015, in a $3,500 report. Release
More stories about rfid
Comments
Post new comment
Paid Research Reports
- Cloud Computing Adoption In The APAC Life Sciences Industry
- Pharmaceutical Licensing Overview
- Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
- Pharmaceutical Key Trends 2010
- Commercial Insight: Top 20 Oncology Therapy Brands in Australia
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities


SHARE
WITH: